Navigation Links
Clinical Trial Participation Today May Lead To Future Breakthroughs In Pancreatic Cancer, One Of The Nation's Deadliest Cancers
Date:1/6/2014

cancer trials, patients always receive either the best standard treatment or the treatment being evaluated in the trial," adds Fleshman. "Thanks to clinical trial research and participation, significant advancements in the field of pancreatic cancer have been made. However, much still lies ahead."

To bring attention to the need for clinical trials and to increase enrollment, the organization's Patient and Liaison Services (PALS) program educates patients and caregivers about their options and the value of clinical trials. The program also conducts personalized searches using the organization's comprehensive, proprietary clinical trials database to determine potential eligibility. This database is the nation's leading resource for pancreatic cancer clinical trials.

To learn more about the Pancreatic Cancer Action Network, the PALS program and clinical trials, visit www.pancan.org/pals.

About the Pancreatic Cancer Action Network
The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase the survival rate for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.

Contact:
Anne Milo
Public Relations Manager
Pancreatic Cancer Action Network
Direct: 310-706-3357
Cell: 562-810-3016
Email: amilo@pancan.org

Video with caption: "Janu
'/>"/>

SOURCE Pancreatic Cancer Action Network
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TauRx Expands Alzheimers Clinical Trials in the United States
2. ideaPoint, Inc. Announces Launch of Multi-Sponsor Portal Providing Researchers Opportunity to Request Access to Clinical Data from Five Global Study Sponsors
3. Cell Therapeutics Announces Removal of the Partial Clinical Hold on Tosedostat
4. CMC Biologics and OncoSynergy Enter into Agreement to Develop and Manufacture Material for IND Enabling Studies and Phase I Clinical Trials
5. Quarterly Dividends, Clinical Trial Results, Dental Exhibition Updates, and Upcoming Presentation Schedules - Research Report Quest Diagnostics, Avanir, Sirona, Ligand and Genomic Health
6. Increased Dividends, Clinical Trial Results, Survey Results, and Updated Financial Guidance - Research Report on Aetna, Biogen, Eli Lilly, WellPoint, and Laboratory Corp. of America
7. Celsion Corporation Announces Combined Clinical Data from Two Phase I Trials at the 2013 San Antonio Breast Cancer Conference
8. Otonomy Doses First Subjects in Phase 3 Clinical Trials of OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery
9. BioLineRx Presents Positive Preclinical Results of Acute Myeloid Leukemia Treatment at ASH Conference
10. Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting
11. Integrated Safety and Efficacy Analysis of Phase 2 Clinical Trials of Pacritinib in Patients with Myelofibrosis and Low Platelet Counts Presented at ASH Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... NEW YORK , Sept. 4, 2015  Cumberland ... Executive Officer, will present live at VirtualInvestorConferences.com on September ... TIME: 2:30p.m. ET LINK: http://tinyurl.com/sep10pre ... online event where investors are invited to ask the ... hall as well as the association,s "virtual trade booth." ...
(Date:9/4/2015)... 4, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), ... generic pharmaceutical company, today announced it has submitted its ... Food and Drug Administration (FDA) of 2015, which brings ... at the FDA to twenty-nine. Jason ... "We believe our current pipeline of twenty-nine submissions, exclusive ...
(Date:9/4/2015)... 2015 Research and Markets ... "Stability Testing of Pharmaceuticals (London, UK - December ... By attending this comprehensive two day seminar delegates will: ... studies that are suitable for global arketing - ... manage stability samples and facilities - Know how ...
Breaking Medicine Technology:Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2
... Calif., July 19, 2011 Cardica, Inc. (Nasdaq: ... Kuthe, M.D., Chief of General Surgery at the ... a total of five laparoscopic procedures using Cardica,s, ... stapling device. These included several sigmoidectomies, an appendectomy ...
... WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... company with operations in China and the United States, ... the second quarter of 2011 after the New York ... will be Thursday morning, August 11, 2011 Shanghai time). ...
Cached Medicine Technology:Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 2Dr. Andreas Kuthe Performs First Laparoscopic Procedures Using Cardica's Microcutter XPRESS™ 30 Surgical Cutting and Stapling Device 3WuXi PharmaTech Schedules Second-Quarter 2011 Earnings Release 2
(Date:9/4/2015)... ... September 04, 2015 , ... San Francisco ... at CitiDent. CEREC is a newer method for creating restorations through innovative imaging ... by eliminating the need for multiple appointments, CEREC produces restorations with total precision ...
(Date:9/4/2015)... ... September 04, 2015 , ... The USC Eye Institute is ... 9 nationwide by Doximity. Faculty, residents and staff are honored to have contributed ... the quality of our ophthalmology residency program. Our faculty places a high priority on ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Benker Residence in South Glastonbury, Connecticut, has been selected for the Residential Award ... significant energy efficiency and resiliency measures. Chosen from a highly competitive field of ...
(Date:9/4/2015)... ... September 04, 2015 , ... Friday night, Chicago lovebirds ... Generation Rescue’s A Night of Hope event supporting families affected by autism, raising nearly ... and Joe Salas, joined together at the Oscar Swan Inn to support the cause. ...
(Date:9/3/2015)... ... September 03, 2015 , ... NanoCytomics LLC today announced the ... that will bring low-cost cancer pre-screening tests to primary care physicians in the ... technology platform detects and measures cellular changes at the nanoscale level. The cellular ...
Breaking Medicine News(10 mins):Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 2Health News:Preora Diagnostics to Commercialize Cancer Pre-screening Tests 3
... Aldridge LLP (MLA) is pleased to announce that Paul ... has joined the firm in our Government Contracts Department. ... firm,s Life Sciences and Public Health Preparedness practice in ... addition to helping clients develop strategies for offering their ...
... deCODE genetics (Nasdaq: DCGN ) today announced that ... Cardio Scan(TM), the unique new tool that,enables individuals to ... atrial fibrillation, intracranial and abdominal aortic,aneurysm, and venous thromboembolism, ... On Thursday, February 5th, just ahead of ...
... SAN FRANCISCO, Feb. 3 Nile Therapeutics, Inc., (Nasdaq: ... Chief Executive Officer, will present a corporate overview at ... New York. The presentation will take place at 3:15 ... room at the Waldorf Astoria Hotel.About Nile Therapeutics , ...
... A Simple Mouse ClickNEW YORK, Feb. 3 ... long outpatient treatments or fighting loneliness after visiting ... break. Colgate-Palmolive is partnering once again with Starlight ... Starlight Fun Centers(TM) to children,s hospitals throughout the ...
... Feb. 3 The Female Health Company (NYSE Alternext: ... conference call to discuss its operating results for the ... (EST) on Tuesday, February 10, 2009. The Company ... the same day. Shareholders and other interested parties may ...
... effect on depressed individuals under 25 remains unclear, ... -- Selective serotonin reuptake inhibitors (SSRIs) may significantly ... in depressed adults, according to a review of ... widely used antidepressants as Celexa, Paxil, Prozac and ...
Cached Medicine News:Health News:Former Assistant Secretary of Defense for Homeland Defense Joins McKenna Long & Aldridge LLP 2Health News:deCODEme(TM) Takes on Heart Disease in February 2Health News:deCODEme(TM) Takes on Heart Disease in February 3Health News:deCODEme(TM) Takes on Heart Disease in February 4Health News:deCODEme(TM) Takes on Heart Disease in February 5Health News:Nile Therapeutics to Present at the 2009 BIO CEO & Investor Conference 2Health News:Colgate-Palmolive Awards Starlight Fun Centers(TM) to Hospitals Through Online Contest 2Health News:Colgate-Palmolive Awards Starlight Fun Centers(TM) to Hospitals Through Online Contest 3Health News:The Female Health Company Schedules First Quarter Conference Call for February 10, 2009 2Health News:SSRI Antidepressants May Lower Adult Suicide Risk 2
... computer-generated Thermal Printing Wristbands and Tags ... thermal and thermal transfer printers. Direct ... a heat-sensitive thermal coating under the ... use heat to transfer highly durable ...
A unique and cost effective one-piece adhesive closure patient bracelet with a tamper- resistant feature that has been designed for patient comfort, caregiver productivity, and long term durability....
... more secure band is desired for adults and where ... is appropriate. The design allows for two bands to ... placed on the wrist and the second to be ... replaced. This is particularly useful in a hospital situation ...
... ID system which combines the IDENTI-MATCH Blood Recipient ... six alert or warning ID bands. It is ... by hospital patients. It integrates the benefits of ... a multipurpose ID band that consolidates admitting and ...
Medicine Products: